MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.maturitas.2025.108620

Медицинская библиотека · Maturitas · 2025

Intravaginal prasterone for urinary urgency in postmenopausal women without urodynamic detrusor overactivity.

Pautasso Stefano, Mancarella Matteo, Novara Lorenzo, Carignano Silvia, Chiadò Piat Francesca, Testa Francesco, Luppi Francesca, Bounous Valentina Elisabetta, Ferrero Annamaria, Sgro Luca Giuseppe

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Symptoms of an overactive bladder are frequently reported in women with genitourinary syndrome of menopause. Despite a frequent association with detrusor overactivity, urodynamic assessment does not always reveal this condition, which suggests a leading role for increased bladder mucosal sensitivity due to hormone deprivation in producing urinary symptoms. The present study assessed the effects of intravaginal prasterone on urgency symptoms in those patients receiving treatment for concurrent vulvovaginal atrophy.

STUDY

DESIGN

This was an observational cohort study on 21 women with genitourinary syndrome of menopause, including urgency symptoms, without detrusor overactivity on urodynamic assessment. Patients received intravaginal prasterone 6.5 mg daily and were reassessed at 12 weeks.

MAIN OUTCOME MEASURES: Urinary symptoms and their impact on the quality of life were evaluated through the Urogenital Distress Inventory (UDI-6) and Overactive Bladder short-form (OAB-Q SF) questionnaires; secondary outcomes included urinary frequency and prevalence of urgency or incontinence as recorded in a voiding diary, and scores on a visual analogue scale (VAS) for vaginal discomfort.

RESULTS

A significant improvement in urinary symptoms was observed in the scores on both the UDI-6 (57.1 +/- 20.7 vs 30.2 +/- 22.7, p < 0.001) and the OAB-Q SF (61.3 +/- 19.7 vs 35.7 +/- 22, p < 0.001); a significant improvement was also reported in terms of better quality of life, diminished VAS scores, and a reduction in incontinence and daily and nocturnal frequency.

CONCLUSIONS

Women complaining of urgency related to genitourinary syndrome of menopause with no urodynamic evidence of detrusor overactivity may benefit from treatment with intravaginal prasterone.

Для цитирования: Pautasso Stefano, Mancarella Matteo, Novara Lorenzo, Carignano Silvia, Chiadò Piat Francesca, Testa Francesco, Luppi Francesca, Bounous Valentina Elisabetta, Ferrero Annamaria, Sgro Luca Giuseppe. Intravaginal prasterone for urinary urgency in postmenopausal women without urodynamic detrusor overactivity.. Maturitas. 2025. DOI: 10.1016/j.maturitas.2025.108620.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.